Goldman Sachs’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.43M | Buy |
|
|||||
|
2025
Q2 | $33.3K | Sell |
|
|||||
|
2025
Q1 | $39.2K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $14.2K | Sell |
|
|||||
|
2024
Q2 | $133K | Sell |
|
|||||
|
2024
Q1 | $641K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $17.6K | Sell |
|
|||||
|
2023
Q1 | $20.2K | Sell |
|
|||||
|
2022
Q4 | $166K | Sell |
|
|||||
|
2022
Q3 | $194K | Sell |
|
|||||
|
2022
Q2 | $343K | Sell |
|
|||||
|
2022
Q1 | $2.03M | Buy |
|
|||||
|
2021
Q4 | $2.76M | Sell |
|
|||||
|
2021
Q3 | $5.64M | Buy |
|
|||||
|
2021
Q2 | $6.03M | Buy |
|
|||||
|
2021
Q1 | $1.62M | Sell |
|
|||||
|
2020
Q4 | $1.49M | Sell |
|
|||||
|
2020
Q3 | $1.86M | Buy |
|
|||||
|
2020
Q2 | $2.31M | Buy |
|
|||||
|
2020
Q1 | $1.06M | Sell |
|
|||||
|
2019
Q4 | $3.33M | Buy |
|
|||||
|
2019
Q3 | $2.87M | Sell |
|
|||||
|
2019
Q2 | $4.56M | Buy |
|
|||||
|
2019
Q1 | $2.12M | Sell |
|
|||||
|
2018
Q4 | $7.52M | Buy |
|
|||||
|
2018
Q3 | $8.44M | Sell |
|
|||||
|
2018
Q2 | $11.9M | Buy |
|
|||||
|
2018
Q1 | $11.9M | Sell |
|
|||||
|
2017
Q4 | $9.66M | Buy |
|
|||||
|
2017
Q3 | $5.91M | Buy |
|
|||||
|
2017
Q2 | $1.98M | Buy |
|
|||||
|
2017
Q1 | $190K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $319K | Buy |
|